Isorhamnetin alleviates lipopolysaccharide-induced inflammatory responses in BV2 microglia by inactivating NF-κB, blocking the TLR4 pathway and reducing ROS generation
- Authors:
- Shin Young Kim
- Cheng‑Yun Jin
- Cheol Hong Kim
- Young Hyun Yoo
- Sung Hyun Choi
- Gi‑Young Kim
- Hyun Min Yoon
- Hwan Tae Park
- Yung Hyun Choi
- Reference:
- International Journal of Molecular Medicine
- 2019
- 43
- 682-692
- DOI:
- 10.3892/ijmm.2018.3993